| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $65.9M | +1941.8% |
| Cost of Revenue | $61.1M | +1864.4% |
| Gross Profit | $4.8M | +4018.1% |
| R&D Expense | $2.1M | +2185.8% |
| SG&A Expense | $7.1M | +240.4% |
| Operating Income | -$9.7M | -210.0% |
| Interest Expense | $13K | -14.7% |
| Pre-tax Income | -$8.9M | -162.2% |
| Income Tax | $77K |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | +219.3% |
| Accounts Receivable | $6.8M | +2594.3% |
| Inventory | $12.7M | +617.5% |
| Current Assets | $23.6M | +445.7% |
| Total Assets | $26.0M | +383.8% |
| Current Liabilities | $30.4M | +239.7% |
| Long-term Debt | $97K | -15.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | -40.2% |
| Capital Expenditures | $68K | +681.6% |
| Investing Cash Flow | -$40K | -360.2% |
| Financing Cash Flow | $7.9M | +128.6% |
| Free Cash Flow | -$6.6M | -41.4% |
| +287.0% |
| Net Income | -$9.0M | -162.9% |
| EPS (Basic) | -$1.47 | +57.1% |
| EPS (Diluted) | -$1.47 | +57.1% |
| Total Liabilities |
| $31.4M |
| +234.5% |
| Stockholders' Equity | -$5.4M | -34.0% |